Aim: This study aimed to determine whether there was a correlation between the systemic immune-inflammation index and ovarian reserve markers such as follicle stimulant hormone, estradiol, and anti-müllerian hormone.
Methods: The study comprised 65 people with premature ovarian insufficiency and 71 controls with similar demographics. The concentrations of hemoglobin, hematocrit, platelets, white blood cells, neutrophils, and lymphocytes were evaluated. The neutrophil leukocyte ratio, platelet lymphocyte ratio, and systemic immune-inflammation index were calculated. The antral follicle count reserves of all patients were evaluated by transvaginal ultrasonography. An independent t-test was used for the comparison of the study and control groups. Correlations between variables were analyzed using Pearson's correlation test. A p value of 0.05 was considered significant.
Results: The results of the neutrophil-to-lymphocyte ratio and the platelet-lymphocyte ratio showed a significant difference between the groups (p = 0.043). The Systemic Immune Inflammation Index value was the statistically significant difference found between the groups. There was a significant positive correlation between the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-lymphocyte ratio, and follicle stimulant hormone, while a significant negative correlation was found between the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-lymphocyte ratio, antral follicle count, and anti-mullerian hormone.
Conclusions: Our study was the first in this field to reveal the relationship between premature ovarian failure and the systemic immune-inflammation index. According to our study results, the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-lymphocyte ratio are significantly higher in individuals with ovarian failure. It can be used as a marker for the diagnosis of premature ovarian insufficiency.